Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Generic Gold Corp | 1WD | Nov 21, 2024 | 0.03 | 0.00 |
Genertec Universal Medical Group Company Limited | 5UM | Nov 21, 2024 | 0.53 | 0.00 |
Genesco Inc. | GN8 | Nov 21, 2024 | 27.00 | -2.17 |
GENESIS AI CORP. | NL8 | Nov 21, 2024 | 0.02 | 0.00 |
GENESIS MINERALS LTD | 3G2 | Nov 21, 2024 | 1.50 | 0.00 |
Genetic Analysis | 8V8 | Nov 21, 2024 | 0.03 | -19.02 |
Genetic Technologies ADR | DU80 | Nov 21, 2024 | 0.69 | 0.00 |
Genetic Technologies Ltd. | DU8 | Nov 21, 2024 | 0.05 | 0.00 |
GeNeuro SA | GEM | Nov 21, 2024 | 0.04 | -0.93 |
Genfit | XUP | Nov 21, 2024 | 4.01 | -2.91 |
GENFIT S.A. - American Depositary Shares | XUPB | Nov 21, 2024 | 3.84 | -3.03 |
Genflow Biosciences Plc | WQ5 | Nov 21, 2024 | 0.02 | 0.00 |
Genie Energy Ltd. Class B | 6GE | Nov 21, 2024 | 14.70 | -0.68 |
GENinCode plc | 9PL | Nov 21, 2024 | 0.04 | 0.00 |
Genius Metals Inc. | 0FU | Nov 21, 2024 | 0.04 | 0.00 |
Genmab | GE9 | Nov 21, 2024 | 193.75 | +0.83 |
Genmab A/S - American Depositary Shares | GE91 | Nov 21, 2024 | 19.30 | +0.52 |
Genomma Lab Internacional SAB | GEKA | Nov 21, 2024 | 1.19 | -4.03 |
Genomtec S.A. | 4VI | Nov 21, 2024 | 1.52 | -0.26 |
Genor Biopharma Holdings Limited | 67N0 | Nov 21, 2024 | 0.16 | +0.63 |
Genovis | 5GV | Nov 21, 2024 | 2.33 | -0.43 |
Genoway | JEH | Nov 21, 2024 | 3.59 | +0.28 |
Genpact Ltd | 35G | Nov 21, 2024 | 43.50 | +3.52 |
Genscript Biotech Corporation | G51 | Nov 21, 2024 | 1.28 | 0.00 |
GenSight Biologics S.A. | G49N | Nov 21, 2024 | 0.27 | -2.34 |
Gensource Potash Corp | UGN | Nov 21, 2024 | 0.04 | +7.50 |
Gentex Corporation | GTX | Nov 21, 2024 | 27.80 | +1.46 |
Gentherm Inc | QA4A | Nov 21, 2024 | 40.40 | +3.06 |
Gentian Diagnostics | 6FK | Nov 21, 2024 | 3.48 | +2.96 |
GENTILI MOSCONI S.P.A | Z5A | Nov 21, 2024 | 2.25 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.